BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6436959)

  • 21. Influence of disodium etidronate on Paget's disease of bone.
    Muir HG; Schabort I; Hough FS
    S Afr Med J; 1987 Oct; 72(7):470-2. PubMed ID: 3116683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
    Labinson P; Taxel P
    Conn Med; 2007 May; 71(5):269-73. PubMed ID: 17526382
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid osteolysis after revision hip arthroplasty in Paget's disease.
    Oakley AP; Matheson JA
    J Arthroplasty; 2003 Feb; 18(2):204-7. PubMed ID: 12629612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective short term treatment of Paget's disease with oral etidronate.
    Preston CJ; Yates AJ; Beneton MN; Russell RG; Gray RE; Smith R; Kanis JA
    Br Med J (Clin Res Ed); 1986 Jan; 292(6513):79-80. PubMed ID: 3080099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risedronate for Paget's disease of bone.
    Med Lett Drugs Ther; 1998 Aug; 40(1034):87-8. PubMed ID: 9731243
    [No Abstract]   [Full Text] [Related]  

  • 26. Etidronate for hypercalcemia of malignancy and osteoporosis.
    Horowitz E; Miller JL; Rose LI
    Am Fam Physician; 1991 Jun; 43(6):2155-9. PubMed ID: 1904188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 29. Etidronate-an oral treatment for Paget's disease of bone.
    Drug Ther Bull; 1982 Apr; 20(7):25-6. PubMed ID: 6804199
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience with sodium etidronate in the treatment of symptomatic Paget's disease of bone.
    Bourke J; Murphy M; Fennelly JJ
    Ir Med J; 1985 Oct; 78(10):300. PubMed ID: 3934108
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
    Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
    J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring the treatment of Paget's disease with etidronate.
    Kanis JA
    Calcif Tissue Int; 1984 Dec; 36(6):629-31. PubMed ID: 6442196
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and radiographic improvement of bone of the second lumbar vertebra in Paget's disease following therapy with etidronate disodium: a case report.
    Nicholas JJ; Helfrich DJ; Cooperstein L; Goodman M
    Arthritis Rheum; 1989 Jun; 32(6):776-9. PubMed ID: 2500130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paget's disease of bone.
    Haddad JG
    Curr Ther Endocrinol Metab; 1994; 5():525-7. PubMed ID: 7704787
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of etidronate (EHDP) in Paget's disease of bone.
    Johnston CC; Khairi MR; Meunier PJ
    Arthritis Rheum; 1980 Oct; 23(10):1172-6. PubMed ID: 6775643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous rapid osteolysis in Paget's disease after internal fixation of subtrochanteric femoral fracture.
    Khurjekar KS; Vidyadhara S; Dheenadhayalan J; Rajasekaran S
    Singapore Med J; 2006 Oct; 47(10):897-900. PubMed ID: 16990967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risedronate: clinical usage.
    Chapurlat RD; Delmas PD
    Int J Clin Pract; 2001 May; 55(4):275-8. PubMed ID: 11406915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
    Gibbs CJ; Aaron JE; Peacock M
    Br Med J (Clin Res Ed); 1986 May; 292(6530):1227-9. PubMed ID: 3085789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.